Universal Tracking Solutions (UTRK.OB) Announces Preliminary 2008 Record Revenue Growth
Universal Tracking Solutions announced that revenue for its fourth quarter ending December 31, 2008 totaled $217,452, which is down approximately…
Blog
Artificial Life, Inc. (ALIF.OB) Reports Strong Financial Results for Year 2008
Today, Artificial Life, Inc. announced its financial results for the fourth quarter of 2008 as well as the full year.…
Convergence Technologies, Inc. (CNVC.PK) Announces Acquisition of Merchant Banking Group
Today shortly before the opening bell, Convergence Technologies announced its acquisition of Bookkeeper International Equities Corp in an all stock…
Kraig Biocraft Laboratories, Inc. (KBLB.OB) Makes Substantial Progress in the Labs; Achieves New Company Record Ahead of Schedule
Today, Kraig Biocraft announced that Dr. Fraser’s research team has successfully made 5,000 genetic transfers in a single week using…
Cleartronic Inc.’s (CLRI.OB) Innovative, Highly Functional Products
Cleartronic Inc., through its wholly owned subsidiary VoiceInterop, offers an array of hardware and software solutions that connect various incompatible…
BoNa Coffee Holdings Corp. (BCHC.PK) is “One to Watch”
BoNa Coffee Holdings Corp. is a holding company trading on the Pink Sheets. The Company's businesses include coffee shops, furniture…
Liquor Group Wholesale Implements Expansion plans in Ohio
Liquor Group Wholesale, Inc. (OTCBB: LIQR) expands operations with new approval to sell high proof spirits to the State of…
Kraig Biocraft Laboratories, Inc. (KBLB.OB) – Innovation in Genetic Engineering
Kraig Biocraft operates in a multi-billion dollar world market that has been growing by as much as 30 percent each…
Stratos Renewables Corp. (SRNW.OB) is Positioned to Take Advantage of the Next Age in Renewable Energy Supply
California-based Stratos Renewables Corp. (SRNW.OB) focuses on integrated sugarcane ethanol production in South America. The development-stage company is designing a…
Albany Molecular Research, Inc. (AMRI) Reports Financial Results for Fourth Quarter of 2008
Albany Molecular Research, Inc. announced that total revenue for the fourth quarter of 2008 was $56.4 million, an increase of…